Confirming the Bidirectional Nature of the Association Between Severe Hypoglycemic and Cardiovascular Events in Type 2 Diabetes: Insights From EXSCEL
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: We sought to confirm a bidirectional association between severe hypoglycemic events (SHEs) and cardiovascular (CV) event risk and to characterize individuals at dual risk. RESEARCH DESIGN AND METHODS: In a post hoc analysis of 14,752 Exenatide Study of Cardiovascular Event Lowering (EXSCEL) participants, we examined time-dependent associations between SHEs and subsequent major adverse cardiac events (CV death, nonfatal myocardial infarction [MI] or stroke), fatal/nonfatal MI, fatal/nonfatal stroke, hospitalization for acute coronary syndrome (hACS), hospitalization for heart failure (hHF), and all-cause mortality (ACM), as well as time-dependent associations between nonfatal CV events and subsequent SHEs. RESULTS: SHEs were uncommon and not associated with once-weekly exenatide therapy (hazard ratio 1.13 [95% CI 0.94–1.36], P = 0.179). In fully adjusted models, SHEs were associated with an increased risk of subsequent ACM (1.83 [1.38–2.42], P < 0.001), CV death (1.60 [1.11–2.30], P = 0.012), and hHF (2.09 [1.37–3.17], P = 0.001), while nonfatal MI (2.02 [1.35–3.01], P = 0.001), nonfatal stroke (2.30 [1.25–4.23], P = 0.007), hACS (2.00 [1.39–2.90], P < 0.001), and hHF (3.24 [1.98–5.30], P < 0.001) were all associated with a subsequent increased risk of SHEs. The elevated bidirectional time-dependent hazards linking SHEs and a composite of all CV events were approximately constant over time, with those individuals at dual risk showing higher comorbidity scores compared with those without. CONCLUSIONS: These findings, showing greater risk of SHEs after CV events as well as greater risk of CV events after SHEs, validate a bidirectional relationship between CV events and SHEs in patients with high comorbidity scores.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A causal relationship between hypoglycaemia and adverse outcomes is not always clear as low glucose levels can be a marker of ill health.139,140”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [140]
In the citing paper
“Similar results were confirmed in other trials.140,187,188”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [140]
In the citing paper
“Although severe hypoglycaemic events were associated with higher HF hospitalization in some but not all studies, there is no clear evidence for causality.139,140,554,568”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [140]
In the citing paper
“Recent analyses have demonstrated bi-directional associations between hypoglycaemia and CV outcomes, including HF, suggesting that this is not causal, but rather reflects underlying frailty and risk of adverse outcomes.139,140”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [140]
In the citing paper
“Although severe hypoglycaemic events were associated with higher HF hospitalization in some but not all studies, there is no clear evidence for causality.139,140,554,568”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [140]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742 · cited 7×
“diabetes (years) 12 (7, 17) 14 (9, 22) 16 (11, 22) 17 (10, 24) 12 (7, 18)”
MethodInfluentialGlucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2015) · Diabetes Care · doi:10.2337/dc14-2441 · Cited by 3,066 · cited 2×
“These findings, and the lack of compelling evidence for CV benefit from intensive glycemic control in patients with established CV disease, have prompted many diabetes management guidelines to suggest relaxing individual glycated hemoglobin (HbA1c) targets in such patients in the anticipation that this will reduce SHE…”
BackgroundSelf-citationAhlqvist, E., Storm, P., Käräjämäki, A., Martinell, M., Dorkhan, M., Carlsson, A., Vikman, P., Prasad, R. B., Aly, D. M., Almgren, P., et al. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30051-2 · Cited by 2,335
Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes
Holman, R. R., Bethel, M. A., Mentz, R. J., Thompson, V. P., Lokhnygina, Y., Buse, J. B., Chan, J. C., Choi, J., Gustavson, S. M., Iqbal, N., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1612917 · Cited by 2,162 · cited 3×
“We sought to confirm in this post hoc analysis of data from EXSCEL (Exenatide Study of Cardiovascular Event Lowering) (16) that there is a bidirectional relationship between an increased risk for CV events after SHEs and an increased risk for SHEs after nonfatal CV events, particularly in patients at dual risk with fe…”
BackgroundResultSelf-citation(2013) · European Heart Journal · doi:10.1093/eurheartj/eht108 · Cited by 1,955
Severe hypoglycemia and risks of vascular events and death
Zoungas, S., Patel, A., Chalmers, J., de Galan, B. E., Li, Q., Billot, L., Woodward, M., Ninomiya, T., Neal, B., MacMahon, S., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003795 · Cited by 1,471
Long-term effects of intensive glucose lowering on cardiovascular outcomes
The ACCORD Study Group (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1006524 · Cited by 1,035
Bonds, D. E., Miller, M. E., Bergenstal, R. M., Buse, J. B., Byington, R. P., Cutler, J. A., Dudl, R. J., Ismail-Beigi, F., Kimel, A. R., Hoogwerf, B., et al. (2010) · BMJ · doi:10.1136/bmj.b4909 · Cited by 933 · cited 5×
“Higher HbA1c targets, however, may increase the risk of microvascular complications in the longer term,andhavenotbeenshownto reduce the risk of SHEs (4,12,13).”
BackgroundResultSelf-citationWhy Summary Comorbidity Measures Such As the Charlson Comorbidity Index and Elixhauser Score Work
Austin, S. R., Wong, Y.-N., Uzzo, R. G., Beck, J. R., & Egleston, B. L. (2015) · Medical Care · doi:10.1097/mlr.0b013e318297429c · Cited by 716 · cited 7×
“diabetes (years) 12 (7, 17) 14 (9, 22) 16 (11, 22) 17 (10, 24) 12 (7, 18)”
MethodInfluential
Cited by
2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes.
Marx, N., Federici, M., Schütt, K., Müller-Wieland, D., Ajjan, R. A., Antunes, M. J., Christodorescu, R. M., Crawford, C., Di Angelantonio, E., Eliasson, B., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad192 · Cited by 1,642
Self-citationThe Lancet Commission on diabetes: using data to transform diabetes care and patient lives
Chan, J. C. N., Lim, L.-L., Wareham, N. J., Shaw, J. E., Orchard, T. J., Zhang, P., Lau, E. S. H., Eliasson, B., Kong, A. P. S., Ezzati, M., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)32374-6 · Cited by 793
Self-citationThe consequences of hypoglycaemia
Amiel, S. A. (2021) · Diabetologia · doi:10.1007/s00125-020-05366-3 · Cited by 223
The double burden: type 1 diabetes and heart failure—a comprehensive review
Julián, M. T., de, A. P.-M., Julve, J., & Alonso, N. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02136-y · Cited by 55
“Although severe hypoglycemic events were associated with higher HF hospitalization [157–160], recent analyses have revealed a bi-directional association between hypoglycemia and CV outcomes, including HF.”
BackgroundMcAlister, F. A., Zheng, Y., Westerhout, C. M., Buse, J. B., Standl, E., McGuire, D. K., de Werf, F. V., Green, J. B., Armstrong, P. W., Holman, R. R., et al. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.1958 · Cited by 36
Self-citationHeller, S. R., Geybels, M. S., Iqbal, A., Liu, L., Wagner, L., & Chow, E. (2021) · Diabetologia · doi:10.1007/s00125-021-05556-7 · Cited by 37
“A bi-directional association between severe hypoglycaemia and cardiovascular events, with greater risk of cardiovascular events after severe hypoglycaemia and vice versa, particularly in individuals with comorbidities, is evident [18].”
BackgroundZaccardi, F., Ling, S., Lawson, C. A., Davies, M. J., & Khunti, K. (2020) · Diabetologia · doi:10.1007/s00125-020-05223-3 · Cited by 38
Abdelhafiz, A. H., Peters, S., & Sinclair, A. J. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.109085 · Cited by 24
Li, G., Zhong, S., Wang, X., & Zhuge, F. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1222409 · Cited by 26
Abdelhafiz, A. H., & SINCLAIR, A. J. (2022) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2022.108144 · Cited by 23
Hypoglycaemia and its management in primary care setting
Ibrahim, M., Baker, J., Cahn, A., Eckel, R. H., El Sayed, N. A., Fischl, A. H., Gaede, P., Leslie, R. D., Pieralice, S., Tuccinardi, D., et al. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3332 · Cited by 21
“Severe hypoglycaemia is almost always related to insulin and sulphonylurea therapy, in both T1DM and T2DM.”
BackgroundInfluentialSelf-citationHow Significant Is Severe Hypoglycemia in Older Adults With Diabetes?
Chow, L. S., & Seaquist, E. R. (2020) · Diabetes Care · doi:10.2337/dci19-0069 · Cited by 21
Grammes, J., Schmid, S., Bozkurt, L., Heinemann, L., Hess, G., Kubiak, T., Küstner, E., Priesterroth, L., Stahl, C., Holl, R. W., et al. (2023) · Diabetic Medicine · doi:10.1111/dme.15261 · Cited by 24
“5,6 Older adults carry a high burden of diabetes: increased risk of hypoglycaemia and hypoglycaemia unawareness can have detrimental effects in this vulnerable population 7,8 pointing towards potential benefits of CGM use.”
BackgroundSevere Hypoglycemia and Risk of Atherosclerotic Cardiovascular Disease in Patients With Diabetes
Rana, J. S., Moffet, H. H., Liu, J. Y., & Karter, A. J. (2021) · Diabetes Care · doi:10.2337/dc20-2798 · Cited by 21
Obesity and its management in primary care setting
Ibrahim, M. A., Ba-Essa, E. M., Alvarez, J. A., Baker, J. C., Bruni, V., Cahn, A., Ceriello, A., Cosentino, F., Davies, M. J., Domenico, F. D., et al. (2025) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2025.109045 · Cited by 21
Self-citationFernando, K., Bain, S. C., Holmes, P., Jones, P. N., & Patel, D. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01116-9 · Cited by 18
Marx, N., Kolkailah, A. A., Rosenstock, J., Johansen, O. E., Cooper, M. E., Alexander, J. H., Toto, R. D., Wanner, C., Espeland, M. A., Mattheus, M., et al. (2024) · JAMA Cardiology · doi:10.1001/jamacardio.2023.4602 · Cited by 17
Standl, E., & Schnell, O. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108054 · Cited by 14
Self-citationSaik, O., & Klimontov, V. V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212419 · Cited by 19
“In diabetes, the link between severe hypoglycemia and cardiovascular events is time-dependent and bidirectional: this means increased cardiovascular risk after severe hypoglycemia, as well as greater risk of severe hypoglycemia after a cardiovascular event [7].”
BackgroundNuzzo, A., Brignoli, A., Ponziani, M. C., Zavattaro, M., Prodam, F., Castello, L. M., Avanzi, G. C., Marzullo, P., & Aimaretti, G. (2021) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2021.09.016 · Cited by 14
Madar, H., Wu, Z., Bandini, A., Perkins, B. A., Messier, V., Pomey, M., Brazeau, A., & RABASA-LHORET, R. P. R. (2022) · Acta Diabetologica · doi:10.1007/s00592-022-01987-9 · Cited by 16
Cardio‐renal‐metabolic disease in primary care setting
Ibrahim, M. A., Ba-Essa, E. M., Baker, J. C., Cahn, A., Ceriello, A., Cosentino, F., Davies, M. J., Eckel, R. H., Gaal, L. V., Gæde, P., et al. (2023) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3755 · Cited by 14
Self-citationMellor, J., Kuznetsov, D., Heller, S. R., Gall, M.-A., Rosilio, M., Amiel, S. A., Ibberson, M. R., McGurnaghan, S. J., Blackbourn, L. A. K., Berthon, W., et al. (2024) · Diabetologia · doi:10.1007/s00125-024-06225-1 · Cited by 16
Runesson, B., Xu, Y., Qureshi, A. R., Lindholm, B., Barany, P. F., Elinder, C. G., & Carrero, J. J. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14051 · Cited by 11
Carreira, A. S., Castro, P., Mira, F. S., Melo, M., Ribeiro, P., & Santos, L. D. C. (2023) · Acta Diabetologica · doi:10.1007/s00592-023-02112-0 · Cited by 12
“Nonetheless, increasing evidence suggests a bidirectional association between severe hypoglycaemia and cardiovascular events in type 2 diabetes, possibly explained by a common at-risk phenotype of frail patients [8, 9].”
BackgroundNguyen, J. V., Roseberry, S., Rivas, J. A., & Cauthon, K. A. B. (2021) · The Senior Care Pharmacist · doi:10.4140/tcp.n.2021.112 · Cited by 10
Standl, E., & Schnell, O. (2025) · Cells · doi:10.3390/cells14080564 · Cited by 10
Self-citationEfficacy and Safety of Naproxen for Acute Pain
Weisman, S. R. (2020) · The Journal of Family Practice · doi:10.12788/jfp.0064 · Cited by 10
Tabesh, M., Sacre, J. W., Mehta, K., Chen, L., Sajjadi, S. F., Magliano, D. J., & Shaw, J. E. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15938 · Cited by 9
Managing the Burden of Dementia-Related Delusions and Hallucinations
Small (2020) · The Journal of Family Practice · doi:10.12788/jfp.0065 · Cited by 6
Song, S. H., & Frier, B. M. (2024) · Diabetic Medicine · doi:10.1111/dme.15466 · Cited by 5
Positionspapier Herzinsuffizienz und Diabetes
Schütt, K. S., Aberle, J., Bauersachs, J. K., Birkenfeld, A. L., Frantz, S., Ganz, M., Jacob, S., Kellerer, M., Leschke, M., Liebetrau, C., et al. (2022) · Diabetologie und Stoffwechsel · doi:10.1055/a-1867-3026 · Cited by 6
Song, S. H., & Frier, B. M. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15170 · Cited by 5
Sullivan, S. D., Freemantle, N., Gupta, R. A., Wu, J., Nicholls, C. J., Westerbacka, J., & Bailey, T. S. (2021) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.306 · Cited by 4
Iqbal, A., Storey, R. F., & Ajjan, R. (2022) · Diabetes · doi:10.2337/dbi22-0028 · Cited by 4
“However, the direct contribution of hypoglycemia to adverse vascular outcomes is under debate, as low glucose levels can be a marker of ill health (2–5), which is supported by the bidirectional relationship between hypoglycemia and CV risk (6,7).”
BackgroundGuideline Development for Medical Device Technology: Issues for Consideration
Battelino, T., Brosius, F. C., Ceriello, A., Cosentino, F., Green, J., Kellerer, M., Koob, S., Kosiborod, M., Lalic, N. M., Marx, N., et al. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221093355 · Cited by 5
“143”
Self-citationShi, K., Zhang, G., Fu, H., Huang, S., Xu, H., Gao, Y., Shi, R., Yan, W., Qian, W., Li, Y., et al. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01944-y · Cited by 3
Positionspapier Herzinsuffizienz und Diabetes
Schütt, K. S., Aberle, J., Bauersachs, J. K., Birkenfeld, A. L., Frantz, S., Ganz, M., Jacob, S., Kellerer, M., Leschke, M., Liebetrau, C., et al. (2022) · Die Kardiologie · doi:10.1007/s12181-022-00562-4 · Cited by 3
Comprehensive Factors for Predicting the Complications of Diabetes Mellitus: A Systematic Review
Erandathi, M., Wang, W. Y. C., Mayo, M., & Lee, C. (2024) · Current Diabetes Reviews · doi:10.2174/0115733998271863231116062601 · Cited by 8
Weir (2020) · The Journal of Family Practice · doi:10.12788/jfp.0068 · Cited by 3
Recognition and Management of Hypoglycemia
Shubrook (2020) · The Journal of Family Practice · doi:10.12788/jfp.0069 · Cited by 3
Ulrich, F. S., Nielsen, M. F., NAPOLI, N., & Burden, A. M. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70548 · Cited by 2
“28,29 While ADA-EASD guidelines have advised limiting sulfonyl-urea use due to their lack of cardio-renal benefit and association with hypoglycaemia and weight gain, their continued use in UK primary care is plausibly driven by cost and accessibility.”
Interdisciplinary assessment and diagnostic algorithm: The role of the cardiologist
Rosano, G. M. C., Vitale, C., & Maltese, G. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108851 · Cited by 2
Out of Sight, Out of Mind: A Call to Action for the Treatment of Hypoglycemia
Goldman, J. D., & Isaacs, D. M. (2024) · Clinical Diabetes · doi:10.2337/cd24-0014 · Cited by 3
Genome-Wide Association Study of Hypoglycemia in Adults With Diabetes in the Million Veteran Program
Raghavan, S., LITKOWSKI, E. M., Jensen, A. E., CHAREST, B. R., Wang, Z., Hui, Q., Chen, H., Rhee, M. K., Leong, A., Meigs, J. B., et al. (2025) · Diabetes · doi:10.2337/db25-0304 · Cited by 1
Worsening Kidney Function and Cardiovascular Outcomes in Type 2 Diabetes and Atherosclerotic Disease
Sharma, A., Razaghizad, A., Stevens, S. R., Lokhnygina, Y. V., Bakris, G. L., Green, J. B., McGuire, D. K., Lópes, R. D., Buse, J. B., Armstrong, P. W., et al. (2026) · JACC Advances · doi:10.1016/j.jacadv.2026.102598 · Cited by 1
Self-citationJayasekera, P. T., Senaratne, T., Lamabadusuriya, D. A., Sathischandra, H., Matthias, A. T., Jayasekera, P., Herath, M., Zoysa, W. D., Senaratne, G., Pathirage, M., et al. (2025) · Journal of Diabetes Research · doi:10.1155/jdr/4412070 · Cited by 2
“[7.2”
InfluentialStandl, E., Ceriello, A., McGuire, D. K., Schnell, O., & Holman, R. R. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02959-3 · Cited by 3
“Undoubtedly, both events may occur closely interrelated in time including acute CV and non-CV death [1, 3, 4, 15, 18, 21, 36–46].”
InfluentialSelf-citationAddressing Nutritional Gaps: Simple Steps for the Primary Care Provider
Quan, Q. (2020) · The Journal of Family Practice · doi:10.12788/jfp.0059 · Cited by 1
An Individualized, Case-Based Approach to the Management of Irritable Bowel Syndrome
Lacy (2020) · The Journal of Family Practice · doi:10.12788/jfp.0060 · Cited by 1
Hot Topics in Primary Care 2020 Introduction
Brunton (2020) · The Journal of Family Practice · doi:10.12788/jfp.0058
Review of LDL-C Lowering with Focus on New and Emerging Agents
Brinton (2020) · The Journal of Family Practice · doi:10.12788/jfp.0070
Stemming the Progression of Diabetic Kidney Disease: The Role of the Primary Care Clinician
Bakris (2020) · The Journal of Family Practice · doi:10.12788/jfp.0072
A New Era in Asthma Management: Assessment of Asthma Control
Murphy, M. (2020) · The Journal of Family Practice · doi:10.12788/jfp.0061
Bidirectional associations in comorbid diseases
Belyalov, F. I. (2021) · Clinical Medicine (Russian Journal) · doi:10.30629/0023-2149-2021-99-3-234-236
(2021) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2020.11.022
Carreira, A., Castro, P., Mira, F. S., Melo, M., Paiva, I., Ribeiro, P. F., & Santos, L. D. C. (2022) · Endocrine Abstracts · doi:10.1530/endoabs.81.yi9
Medizin, S. (2020) · MMW - Fortschritte der Medizin · doi:10.1007/s15006-020-0277-2
Fan, R., Xie, L., Peng, X., Yu, B., Zou, H., Huang, J., Yu, X., Wang, D. W., & Yang, Y. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s369152 · Cited by 1
Ko, S. (2022) · Cardiovascular Prevention and Pharmacotherapy · doi:10.36011/cpp.2022.4.e13 · Cited by 1
Series: Cardiovascular outcome trials for diabetes drugs.
Fisher, M. (2022) · British Journal of Diabetes · doi:10.15277/bjd.2022.387
Les hypoglycémies iatrogènes : impacts immédiats et à long terme
Monnier, L., & Colette, C. (2024) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2024.02.001 · Cited by 1
Addressing Hypoglycemia Risk During Care Transitions
Clements, J. N., Neumiller, J. J., & Triplitt, C. L. (2024) · ADCES in Practice · doi:10.1177/2633559x241280302
Kardiyovasküler Hastalıklarda Hemşirelik Rehberi
ÇİÇEKLİ, N., Kavak, Ş. N., Fidan, H. E., Aldemir, G., Özgün, Y., Sezer, G. N., Ozdemir, R., Doğruyol, A., Bahçeci, S., Çetin, A., et al. (2024) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.3245
Continuous glucose monitoring in patients with type 2 diabetes mellitus on oral hypoglycemic therapy
Кузина, И. А., Акрамовна, Э. Э., & Petunina, N. A. (2025) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2025-414
Pagel, P. S., Hang, D., Freed, J. K., & Crystal, G. J. (2026) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2026.07.032
Metadata
- Authors
- Standl, E., Stevens, S. R., Lokhnygina, Y., Bethel, M. A., Buse, J. B., Gustavson, S. M., Maggioni, A. P., Mentz, R. J., Hernandez, A. F., & Holman, R. R.
- Affiliations
- Helmholtz Munich (DE)
- Duke University (US)
- University of Oxford (GB)
- University of North Carolina at Chapel Hill (US)
- AstraZeneca (United States) (US)
- Associazione Nazionale Medici Cardiologi Ospedalieri (IT)
- Corresponding author
- Standl, Eberhard
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2020-03-01
- Volume
- 43
- Issue
- 3
- Pages
- 643-652
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2997790100
- Cited by
- 65
- References
- 38
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 9 · 2023: 7 · 2022: 10 · 2021: 12 · 2020: 19
- FWCI
- 8.32
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- UNC Libraries
- Funders
- Amgen
- Eli Lilly and Company
- Amylin Pharmaceuticals
- AstraZeneca
- GlaxoSmithKline
- Sanofi
- Boston Scientific Corporation
- MannKind Corporation
- Fresenius Medical Care North America
- MyoKardia
- Zafgen
- National Institute for Health and Care Research (NF-SI-0515-10096)
- Novo Nordisk
- Servier
- National Institutes of Health (UL1TR002489)
- Genentech
- Duke Clinical Research Institute
- Daiichi Sankyo Europe
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- cardiovascular events, type 2 diabetes, bidirectional relationship, exenatide, GLP-1 receptor agonists, major adverse cardiovascular events, heart failure hospitalization, myocardial infarction, stroke, all-cause mortality, comorbidities, EXSCEL trial
- MeSH terms
- Exenatide, Aged, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Diabetic Angiopathies, Double-Blind Method, Female, Hospitalization, Humans, Hypoglycemia, Hypoglycemic Agents, Male, Middle Aged, Myocardial Infarction, Risk Factors, Severity of Illness Index, Comorbidity, Stroke, Acute Coronary Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.